Watanabe Satoshi 渡部聡

… Alternative Names

渡部聡ワタナベサトシ

WATANABE Satoshi 渡部聡

Less

Researcher Number	50529740
Other IDs	https://orcid.org/0000-0003-0041-6981
Affiliation (Current)	2024: 新潟大学, 医歯学総合病院, 講師 2024: 新潟大学, 医学部, 医学部准教授
Affiliation (based on the past Project Information) *help	2019 – 2022: 新潟大学, 医歯学総合病院, 講師 2013 – 2017: 新潟大学, 医歯学総合病院, 助教 2014: 新潟大学, 医歯学総合病院, 特任助教 2011 – 2012: 新潟大学, 医歯学総合病院, 特任助教 2010: 新潟大学, 医歯学系, 非常勤講師 2009: Niigata University, 医歯学総合病院, 医員
Review Section/Research Field	Principal Investigator Respiratory organ internal medicine Except Principal Investigator Respiratory organ internal medicine / Basic Section 53040:Nephrology-related
Keywords	Principal Investigator lymphodepletion / 腫瘍免疫療法 / 抑制性T細胞 / adoptive immunotherapy / Adoptive immunotherapy / PD-L1 / T細胞 / PD-1 / 免疫療法 / regulatory T cells … More / tumor immunotherapy / regulatory T cell / 細胞療法 / 肺癌 / 腫瘍免疫 / lung cancer / Regulatory T cells / Tumor immunotherapy / 放射線療法 / 抗腫瘍免疫療法 / MDSC / 化学療法 / 非特異的肺疾患癌 / その他 / 呼吸器感染症 / 肺線維症 / 非閉塞性肺疾患癌 … More Except Principal Investigator 薬剤性腎障害 / シスプラチン / バンコマイシン / シラスタチン / メガリン / αGalCel / 制御性T細胞 / Regulatory T細胞 / Predictive factor / MDSCs / EGFR-TKI / Lung cancer / 末梢血循環腫瘍細胞 / 術後再発 / 肺癌 Less

メガリンを標的とした薬剤性腎障害治療戦略の開発
- Principal Investigator
  
  青木信将
- Project Period (FY)
  2019 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53040:Nephrology-related
- Research Institution
  Niigata University
Novel antitumor immunotherapy via immune reconstitution after chemotherapy for advanced lung cancerPrincipal Investigator
- Principal Investigator
  
  Watanabe Satoshi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Search of the effect predictive factor in molecules target therapy for lung cancer
- Principal Investigator
  
  YOSHIZAWA Hirohisa
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Novel tumor immunotharapy for advanced lung cancer using homeostatic reconstitution of antitumor immunityPrincipal Investigator
- Principal Investigator
  
  WATANABE Satoshi
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Development of system to predict postoperative recurrence of lung cancer/order-made treatment using peripheral blood circukationg tumor cell
- Principal Investigator
  
  YOSHIZAWA Hirohisa
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University
Effective cancer immunotherapy for advanced lung cancer during homeostatic proliferationPrincipal Investigator
- Principal Investigator
  
  WATANABE Satoshi
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Respiratory organ internal medicine
- Research Institution
  Niigata University

All 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 Other

All Journal Article Presentation

[Journal Article] Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung2018
- Author(s)
  Okamoto Tatsuro、Takada Kazuki、Sato Seijiro、Toyokawa Gouji、Tagawa Tetsuzo、Shoji Fumihiro、Nakanishi Ryota、Oki Eiji、Koike Terumoto、Nagahashi Masayuki、Ichikawa Hiroshi、Shimada Yoshifumi、Watanabe Satoshi、Kikuchi Toshiaki、Akazawa Kouhei、Lyle Stephen、Takabe Kazuaki、Okuda Shujiro、Sugio Kenji
- Journal Title
  
  Annals of Surgical Oncology
  
  Volume: 25 Issue: 6 Pages: 1564-1571
- DOI
  10.1245/s10434-018-6401-1
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-15K10235, KAKENHI-PROJECT-15K10263, KAKENHI-PROJECT-15K15316, KAKENHI-PROJECT-15H05792
[Journal Article] Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations.2018
- Author(s)
  Oizumi S, Sugawara S, Minato K, Harada T, Inoue A, Fujita Y, Maemondo M, Watanabe S, Ito K, Gemma A, Demura Y, Fukumoto S, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Aiba K, Nukiwa T.
- Journal Title
  
  ESMO Open
  
  Volume: 3(2) Issue: 2 Pages: e000313-e000313
- DOI
  10.1136/esmoopen-2017-000313
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09562, KAKENHI-PROJECT-17K09639, KAKENHI-PROJECT-15K09164, KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-15K09237
[Journal Article] A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer2018
- Author(s)
  Kondo Rie、Watanabe Satoshi、Shoji Satoshi、Ichikawa Kosuke、Abe Tetsuya、Baba Junko、Tanaka Junta、Tsukada Hiroki、Terada Masaki、Sato Kazuhiro、Maruyama Yoshie、Makino Masato、Hirata Akira、Tanaka Hiroshi、Koya Toshiyuki、Yoshizawa Hirohisa、Kikuchi Toshiaki
- Journal Title
  
  Oncology
  
  Volume: 94 Issue: 4 Pages: 223-232
- DOI
  10.1159/000486622
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-18KT0019
[Journal Article] Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma2018
- Author(s)
  Sato Seijiro、Nagahashi Masayuki、Koike Terumoto、Ichikawa Hiroshi、Shimada Yoshifumi、Watanabe Satoshi、Kikuchi Toshiaki、Takada Kazuki、Nakanishi Ryota、Oki Eiji、Okamoto Tatsuro、Akazawa Kouhei、Lyle Stephen、Ling Yiwei、Takabe Kazuaki、Okuda Shujiro、Wakai Toshifumi、Tsuchida Masanori
- Journal Title
  
  Scientific Reports
  
  Volume: 8 Issue: 1 Pages: 1-10
- DOI
  10.1038/s41598-017-18560-y
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-15K10235, KAKENHI-PROJECT-18KT0019
[Journal Article] Effect of Lymphodepletion on Donor T Cells and the Role of Recipient Cells Persisting after Cytotoxic Treatments in Cancer Immunotherapies2017
- Author(s)
  Watanabe Satoshi、Arita Masashi、Takahashi Miho、Saida Yu、Koya Toshiyuki、Kikuchi Toshiaki
- Journal Title
  
  Critical Reviews in Immunology
  
  Volume: 37 Issue: 1 Pages: 59-73
- DOI
  10.1615/critrevimmunol.2018019497
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-15K15316
[Journal Article] Transfer of in vitro-expanded na?ve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells2017
- Author(s)
  Tanaka Tomohiro、Watanabe Satoshi、Takahashi Miho、Sato Ko、Saida Yu、Baba Junko、Arita Masashi、Sato Miyuki、Ohtsubo Aya、Shoji Satoshi、Nozaki Koichiro、Ichikawa Kosuke、Kondo Rie、Aoki Nobumasa、Ohshima Yasuyoshi、Sakagami Takuro、Abe Tetsuya、Moro Hiroshi、Koya Toshiyuki、Tanaka Junta
- Journal Title
  
  PLOS ONE
  
  Volume: 12 Issue: 8 Pages: e0183976-e0183976
- DOI
  10.1371/journal.pone.0183976
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168, KAKENHI-PROJECT-15K15316
[Journal Article] Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.2016
- Author(s)
  Ko Sato, Satoshi Watanabe,corresponding author Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Tomohiro Tanaka, Koichiro Nozaki, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Takuro Sakagami, Toshiyuki Koya, Hiroshi Kagamu, Hirohisa Yoshizawa, and Ichiei Narita
- Journal Title
  
  BMC Cancer
  
  Volume: 16(1) Issue: 1 Pages: 222-222
- DOI
  10.1186/s12885-016-2271-8
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25860637, KAKENHI-PROJECT-26293196, KAKENHI-PROJECT-15K09168
[Journal Article] Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.2015
- Author(s)
  Saida Y, Watanabe S, Tanaka T, Baba J, Sato K, Shoji S, Igarashi N, Kondo R, Okajima M, Koshio J, Ichikawa K, Nozaki K, Ishikawa D, Koya T, Miura S, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I
- Journal Title
  
  Journal of immunology
  
  Volume: 195 Pages: 726-735
- Peer Reviewed / Acknowledgement Compliant / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Journal Article] Advanced thymic cancer treated with carboplatin and paclitaxel in a patient undergoing hemodialysis.2015
- Author(s)
  Miura S, Watanabe S (他12名8番目）
- Journal Title
  
  Internal medicine
  
  Volume: 54 Pages: 55-58
- NAID
  130004902998
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] A case of thymic cancer effectively treated by weekly paclitaxel combined with carboplatin2014
- Author(s)
  Kondo R, Watanabe S (他12名2番目）
- Journal Title
  
  Gan To Kagaku Ryoho
  
  Volume: 41 Pages: 2607-2609
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.2014
- Author(s)
  Nozaki K, Watanabe S (他8名8番目）
- Journal Title
  
  PLoS One
  
  Volume: 9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q.2014
- Author(s)
  Watanabe S, Yoshizawa H et al.
- Journal Title
  
  J Thorac Oncol.
  
  Volume: 11 Issue: 2 Pages: 189-94
- DOI
  10.1097/jto.0000000000000048
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25461172
[Journal Article] The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy.2013
- Author(s)
  Miura S, Watanabe S, Sato K, Makino M, Kobayashi O, Miyao H, Iwashima A, Okajima M, Tanaka J, Tanaka H, Kagamu H, Yokoyama A, Narita I, Yoshizawa H.
- Journal Title
  
  Support Care Cancer
  
  Volume: 21 Issue: 9 Pages: 2575-2581
- DOI
  10.1007/s00520-013-1835-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25860637
[Journal Article] DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells2013
- Author(s)
  Koshio, J. Kagamu, H. Nozaki, K. Saida, Y. Tanaka, T. Shoji, S. Igarashi, N. Miura, S. Okajima, M. Watanabe, S. Yoshizawa, H. Narita, I.
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 62 Issue: 10 Pages: 1619-28
- DOI
  10.1007/s00262-013-1467-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23591141, KAKENHI-PROJECT-24591156, KAKENHI-PROJECT-25860637
[Journal Article] Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia2012
- Author(s)
  Baba J, Watanabe S, Saida Y, Tanaka T, Miyabayashi T, Koshio J, Ichikawa K, Nozaki K, Koya T, Deguchi K, Tan C, Miura S, Tanaka H, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I.
- Journal Title
  
  Blood
  
  Volume: 12 Pages: 2417-2427
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591156
[Journal Article] Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia.2012
- Author(s)
  Baba J, Watanabe S, Saida Y, Tanaka T, Miyabayashi T, Koshio J, Ichikawa K, Nozaki K, Koya T, Deguchi K, Tan C, Miura S, Tanaka H, Tanaka J, Kagamu H, Yoshizawa H, Nakata K, Narita I.
- Journal Title
  
  Blood
  
  Volume: 120 Pages: 2417-2427
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity.2012
- Author(s)
  Ichikawa K, Kagamu H, Koyama K, Miyabayashi T, Koshio J, Miura S, Watanabe S, Yoshizawa H, Narita I.
- Journal Title
  
  Vaccine
  
  Volume: 30 Pages: 6190-6197
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24591157
[Journal Article] Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy : a retrospective analysis2011
- Author(s)
  Watanabe S, Yoshizawa H, et al
- Journal Title
  
  BMC Cancer
  
  Volume: 11 Pages: 1-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983
[Journal Article] Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor2011
- Author(s)
  Miyabayashi T, Yoshizawa H, et al
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 11 Issue: 11 Pages: 1597-608
- DOI
  10.1007/s00262-011-1063-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590983, KAKENHI-PROJECT-21590984, KAKENHI-PROJECT-23591141
[Journal Article] Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy : a retrospective analysis2011
- Author(s)
  渡部聡、田中純太、太田毅、近藤利恵、田中洋史、各務博、市川紘将、古塩純、馬場順子、宮林貴大、成田一衛、吉澤弘久
- Journal Title
  
  BMC Cancer
  
  Pages: 1-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] Clinical responses to EGFR-tyrosine kinase inhibitor retreatmentin non-small cell lung cancer patients who benefited from prioreffective gefitinib therapy a retrospective analysis.2011
- Author(s)
  渡部聡、田中純太、太田毅、近藤利恵、田中洋史、各務博、市川紘将、古塩純、馬場順子、宮林貴大、成田一衛、吉澤弘久
- Journal Title
  
  BMC Cancer
  
  Volume: 11 Pages: 1-7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] Henoch Schonlein purpura associated with pulmonary adenocarcinoma2011
- Author(s)
  三船大樹、渡部聡、近藤利恵、和田庸子、森山寛史、各務博、吉沢弘久、手塚貴文、松山麻子、成田一衛
- Journal Title
  
  Journal of medical case report
  
  Volume: 5 Pages: 226-226
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] Vaccination with CD133(+) melanoma induces specific Th17 and Th1 cell-mediated antitumor reactivity against parental tumor2011
- Author(s)
  宮林貴大、各務博、渡部聡、吉澤弘久、成田一衛
- Journal Title
  
  Cancer Immunol Immunother
  
  Pages: 1597-608
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21590984
[Journal Article] 喫煙再開により再燃を認めた急性好酸球性肺炎の1例2010
- Author(s)
  三船大樹、渡部聡、近藤利恵、森山寛史、各務博、高田俊範、成田一衛、長谷川隆志、鈴木栄一、手塚貴文
- Journal Title
  
  新潟医学会雑誌
  
  Pages: 407-412
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Lymphodepletion induces T cell homeostatic proliferation and augments antitumor effects of PD-1/PD-L1 blockade therapy.2017
- Author(s)
  Masashi Arita, Satoshi Watanabe, Miho Takahashi, Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, Rie Kondo, Tetsuya Abe, Junta Tanaka, Toshiyuki Koya, Toshiaki Kikuchi
- Organizer
  American Association for Cancer Research
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Presentation] Programmed death receptor-1/programmed death receptor ligand-1 blockade improves priming of antitumor effector T cells after cytotoxic therapies2016
- Author(s)
  Miho Takahashi, Satoshi Watanabe, Ko Sato, Tomohiro Tanaka, Yu Saida, Junko Baba, Aya Ohtsubo, Miyuki Sato, Rie Kondo, Masaaki Okajima, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Toshiaki Kikuchi
- Organizer
  Annual meeting of american association for cancer research
- Place of Presentation
  New Orleans (アメリカ合衆国)
- Year and Date
  2016-04-16
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Presentation] Critical roles of chemo-resistant effector and regulatory T cells in cancer immunotherapy during hemostatic proliferation2015
- Author(s)
  Ko Sato, Satoshi Watanabe, Yu Saida, Tomohiro Tanaka, Junko Baba, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  Annual meeting of american association for cancer research
- Place of Presentation
  Philadelphia, USA
- Year and Date
  2015-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09168
[Presentation] Gefitinib for non-small cell lung cancer (NSCLC) with minor EGFR mutations: A retrospective study from the North East Japan Study Group (NEJ)2012
- Author(s)
  Watanabe S, Yoshizawa H. et al.
- Organizer
  2012 ESMO Congress
- Place of Presentation
  ウイーン、オーストリア
- Data Source
  KAKENHI-PROJECT-24591156
[Presentation] Combination of cyclophosphamide and inhibition of chemo-resistant　suppressor cells successfully treated advanced tumors.2012
- Author(s)
  Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koichirou Nozaki, Kosuke Ichikawa, Jun Koshio, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  日本癌学会
- Place of Presentation
  札幌
- Data Source
  KAKENHI-PROJECT-24591157
[Presentation] Successful treatment of advanced tumors with chemo-immunotherapy : a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells2012
- Author(s)
  才田優、渡部聡、田中知宏、馬場順子、市川紘将、古塩純、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Successful treatment of advanced tumors with chemo-immunotherapy: a combination of cyclophosphamide and inhibition of chemo-resistant immune suppressor cells.2012
- Author(s)
  Yu Saida, Satoshi Watanabe, Tomohiro Tanaka, Junko Baba, Koichirou Nozaki, Kosuke Ichikawa, Jun Koshio, Satoru Miura, Junta Tanaka, Hiroshi Kagamu, Hirohisa Yoshizawa, Ichiei Narita
- Organizer
  American assocation of cancer research
- Place of Presentation
  Chicago, USA
- Data Source
  KAKENHI-PROJECT-24591157
[Presentation] Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy.2011
- Author(s)
  Watanabe S, Yoshizawa H, et al.
- Organizer
  Lung cancer Early and Metastatic. European Society for Medical Onocology
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy. Lung cancer Early and Metastatic2011
- Author(s)
  Watanabe S, Yoshizawa H, et al.
- Organizer
  European Society for Medical Onocology
- Place of Presentation
  ストックホルム
- Year and Date
  2011-09-24
- Data Source
  KAKENHI-PROJECT-21590983
[Presentation] Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naive mice augments antitumor response2011
- Author(s)
  馬場順子、渡部聡、才田優、市川紘将、古塩純、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Conditioning for cancer immunotherapy ; ex vivo expanded T cells effectively develop into effectors in lymphopenic hosts2011
- Author(s)
  才田優、渡部聡、馬場順子、市川紘将、古塩純、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Irradiation and reconstitution with in vitro-expanded polyclonal T cells from naive mice augment antitumor response2011
- Author(s)
  馬場順子、渡部聡、古塩純、市川紘将、田中洋史、田中純太、各務博、吉澤弘久、成田一衛
- Organizer
  American association for cancer research
- Place of Presentation
  オーランド(招待講演)
- Year and Date
  2011-04-04
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Regulatory T cells resistant to cytotoxic regimens prevent antitumor immunity during T cell homeostatic proliferation2010
- Author(s)
  馬場順子、渡部聡、市川紘将、古塩純、宮林貴大、田中純太、田中洋史、各務博、吉澤弘久、成田一衛
- Organizer
  日本癌学会
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Chemo-resistant regulatory T cells inhibit the augmentation of antitumor immunity during homeostatic T cell proliferation2010
- Author(s)
  馬場順子、渡部聡、市川紘将、古塩純、宮林貴大、田中純太、田中洋史、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Depletion of radio-resistant peripheral regulatory T cells enhances the antitumor immune response during homeostatic proliferation2009
- Author(s)
  馬場順子、渡部聡、市川紘将、古塩純、宮林貴大、田中純太、田中洋史、各務博、吉澤弘久、成田一衛
- Organizer
  American association of cancer research
- Data Source
  KAKENHI-PROJECT-21590984
[Presentation] Dendritic cell vaccination and regulatory T-cell depletion augment antitumor immunity after cytotoxic therapy
- Author(s)
  Tanaka T, Watanabe S(他14名中2番目)
- Organizer
  American Association for Cancer Research
- Place of Presentation
  San Diego, USA, San Diego Convention Center
- Year and Date
  2014-04-05 – 2014-04-09
- Data Source
  KAKENHI-PROJECT-24591157
[Presentation] Critical roles of chemo-resistant effector and regulatory T cells in antitumor immunity after cytotoxic therapy
- Author(s)
  Sato K, Watanabe S(他12名中2番目）
- Organizer
  日本癌学会
- Place of Presentation
  横浜, パシフィコ横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-24591157

1. NAKATA Koh (80207802)

# of Collaborated Projects: 5 results

# of Collaborated Products: 3 results
2. YOSHIZAWA Hirohisa (50282984)

# of Collaborated Projects: 5 results

# of Collaborated Products: 26 results
3. KAGAMU Hiroshi (30418686)

# of Collaborated Projects: 3 results

# of Collaborated Products: 20 results
4. MIURA Satoru (70420320)

# of Collaborated Projects: 2 results

# of Collaborated Products: 7 results
5. 青木信将 (60646933)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 斎藤亮彦 (80293207)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. INOUE Kenich

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 小林国彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 岡島正明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Watanabe Satoshi 渡部 聡

渡部 聡 ワタナベ サトシ

WATANABE Satoshi 渡部 聡

Research Projects

Research Products

Co-Researchers

メガリンを標的とした薬剤性腎障害治療戦略の開発

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Novel antitumor immunotherapy via immune reconstitution after chemotherapy for advanced lung cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Search of the effect predictive factor in molecules target therapy for lung cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Novel tumor immunotharapy for advanced lung cancer using homeostatic reconstitution of antitumor immunityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of system to predict postoperative recurrence of lung cancer/order-made treatment using peripheral blood circukationg tumor cell

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Effective cancer immunotherapy for advanced lung cancer during homeostatic proliferationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] A Phase II Study of Irinotecan for Patients with Previously Treated Small-Cell Lung Cancer2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Effect of Lymphodepletion on Donor T Cells and the Role of Recipient Cells Persisting after Cytotoxic Treatments in Cancer Immunotherapies2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Transfer of in vitro-expanded na?ve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.2015

Author(s)

Journal Title

Watanabe Satoshi 渡部聡

渡部聡ワタナベサトシ

WATANABE Satoshi 渡部聡